PRMT5 Regulates RNA M6A Demethylation for Doxorubicin Sensitivity in Breast Cancer

0
105
Scientists found that doxorubicin treatment significantly induced RNA m6A methylation in breast cancer cells in both a dose- and time-dependent manner.
[Molecular Therapy]
AbstractGraphical Abstract